| Serial Number | 98377540 |
| Word Mark | TAKEDA |
| Filing Date | Friday, January 26, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, February 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 18, 2025 |
| Goods and Services | Medical devices used for administering pharmaceutical preparations for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting pharmaceutical preparations for use in treating or diagnosing disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting and administering pharmaceutical preparations. for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | Wednesday, January 1, 2020 |
| First Use In Commerce Date | Wednesday, January 1, 2020 |
| Party Name | Takeda Pharmaceutical Company Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 541-0045 JP |
| Party Name | Takeda Pharmaceutical Company Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 541-0045 JP |
| Event Date | Event Description |
| Friday, January 26, 2024 | NEW APPLICATION ENTERED |
| Wednesday, July 31, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 21, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 21, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 21, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, August 21, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 3, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 3, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 7, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, October 7, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, October 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 23, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 12, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 18, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 18, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, January 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |